View Future GrowthValiantLtd 과거 순이익 실적과거 기준 점검 4/6ValiantLtd의 수입은 연평균 -17.1%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 5.6% 감소했습니다. 매출은 연평균 2.7%의 비율로 감소해 왔습니다. ValiantLtd의 자기자본이익률은 4.9%이고 순이익률은 7.6%입니다.핵심 정보-17.14%순이익 성장률-17.62%주당순이익(EPS) 성장률Chemicals 산업 성장률12.10%매출 성장률-2.71%자기자본이익률4.90%순이익률7.56%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.모든 업데이트 보기Recent updatesReported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.공시 • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025Declared Dividend • Jun 01Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 67% lower than last year. Ex-date: 6th June 2025 Payment date: 6th June 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (42% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 139% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.Board Change • Apr 30High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman of the Supervisory Board Lei Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (down from CN¥0.11 in 1Q 2024). Revenue: CN¥861.2m (down 8.2% from 1Q 2024). Net income: CN¥79.9m (down 19% from 1Q 2024). Profit margin: 9.3% (down from 11% in 1Q 2024). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaBuy Or Sell Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock has risen 3.7% to CN¥10.99. The fair value is estimated to be CN¥13.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025분석 기사 • Mar 25Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its EarningsValiant Co.,Ltd's ( SZSE:002643 ) price-to-earnings (or "P/E") ratio of 21.4x might make it look like a buy right now...분석 기사 • Mar 07There Are Reasons To Feel Uneasy About ValiantLtd's (SZSE:002643) Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...분석 기사 • Feb 21We Think ValiantLtd (SZSE:002643) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Buy Or Sell Opportunity • Feb 13Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥10.79. The fair value is estimated to be CN¥13.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.60, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.59 per share.Buy Or Sell Opportunity • Jan 02Now 24% undervaluedOver the last 90 days, the stock has risen 9.0% to CN¥11.30. The fair value is estimated to be CN¥14.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025분석 기사 • Dec 18Calculating The Fair Value Of Valiant Co.,Ltd (SZSE:002643)Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥14.68 Current share price...분석 기사 • Dec 04Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 31% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have continued their recent momentum with a 31% gain in the last month alone...Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.42, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.52 per share.분석 기사 • Nov 26ValiantLtd (SZSE:002643) Could Be Struggling To Allocate CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.분석 기사 • Nov 05ValiantLtd's (SZSE:002643) Shareholders Have More To Worry About Than Only Soft EarningsThe market wasn't impressed with the soft earnings from Valiant Co.,Ltd ( SZSE:002643 ) recently. We did some analysis...Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.Buy Or Sell Opportunity • Oct 11Now 20% undervaluedOver the last 90 days, the stock has risen 2.1% to CN¥9.77. The fair value is estimated to be CN¥12.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.분석 기사 • Oct 08Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 40% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have had a really impressive month, gaining 40% after a shaky period beforehand...공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.08 per share.분석 기사 • Sep 05Are Investors Undervaluing Valiant Co.,Ltd (SZSE:002643) By 30%?Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥12.10 ValiantLtd's...Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.Price Target Changed • Aug 27Price target decreased by 9.2% to CN¥16.63Down from CN¥18.31, the current price target is an average from 4 analysts. New target price is 107% above last closing price of CN¥8.03. Stock is down 54% over the past year. The company is forecast to post earnings per share of CN¥0.90 for next year compared to CN¥0.84 last year.Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.분석 기사 • Aug 19Lacklustre Performance Is Driving Valiant Co.,Ltd's (SZSE:002643) Low P/EWith a price-to-earnings (or "P/E") ratio of 11.7x Valiant Co.,Ltd ( SZSE:002643 ) may be sending very bullish signals...분석 기사 • Jul 18We Think ValiantLtd (SZSE:002643) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...공시 • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024분석 기사 • Jun 21Return Trends At ValiantLtd (SZSE:002643) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...분석 기사 • Jun 02ValiantLtd (SZSE:002643) Has Announced That It Will Be Increasing Its Dividend To CN¥0.30Valiant Co.,Ltd ( SZSE:002643 ) will increase its dividend on the 6th of June to CN¥0.30, which is 1.7% higher than...Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.Major Estimate Revision • May 23Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2024 has been updated. 2024 consensus EPS increased from CN¥0.831 to CN¥0.947. Revenues were reaffirmed at CN¥4.86b. Net income forecast to grow 36% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥18.25. Share price was steady at CN¥11.44 over the past week.분석 기사 • Apr 26Solid Earnings May Not Tell The Whole Story For ValiantLtd (SZSE:002643)The stock price didn't jump after Valiant Co.,Ltd ( SZSE:002643 ) posted decent earnings last week. We did some digging...Major Estimate Revision • Apr 26Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥5.58b to CN¥4.86b. EPS estimate fell from CN¥1.04 to CN¥0.831 per share. Net income forecast to grow 21% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥20.64 to CN¥18.31. Share price fell 8.4% to CN¥11.31 over the past week.분석 기사 • Apr 23What Does The Future Hold For Valiant Co.,Ltd (SZSE:002643)? These Analysts Have Been Cutting Their EstimatesThe analysts covering Valiant Co.,Ltd ( SZSE:002643 ) delivered a dose of negativity to shareholders today, by making a...Price Target Changed • Apr 22Price target decreased by 7.3% to CN¥19.14Down from CN¥20.64, the current price target is an average from 4 analysts. New target price is 72% above last closing price of CN¥11.12. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.84 last year.공시 • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 08Price target decreased by 12% to CN¥20.64Down from CN¥23.54, the current price target is an average from 4 analysts. New target price is 58% above last closing price of CN¥13.02. Stock is down 26% over the past year. The company is forecast to post earnings per share of CN¥0.85 for next year compared to CN¥0.79 last year.공시 • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024분석 기사 • Mar 22ValiantLtd (SZSE:002643) Has More To Do To Multiply In Value Going ForwardDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...분석 기사 • Mar 06Valiant Co.,Ltd's (SZSE:002643) Shares Leap 27% Yet They're Still Not Telling The Full StoryThose holding Valiant Co.,Ltd ( SZSE:002643 ) shares would be relieved that the share price has rebounded 27% in the...분석 기사 • Feb 28Is Valiant Co.,Ltd (SZSE:002643) Potentially Undervalued?While Valiant Co.,Ltd ( SZSE:002643 ) might not have the largest market cap around , it received a lot of attention...Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.공시 • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Nov 01Third quarter 2023 earnings: EPS exceeds analyst expectationsThird quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Major Estimate Revision • Oct 30Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.91b to CN¥4.37b. EPS estimate unchanged at CN¥0.881 per share. Net income forecast to grow 47% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 8.8% to CN¥16.97 over the past week.공시 • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.Reported Earnings • Aug 19Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 6.7%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.공시 • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Apr 21Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.80b to CN¥5.14b. EPS estimate fell from CN¥1.10 to CN¥0.923 per share. Net income forecast to grow 9.3% next year vs 38% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥22.59. Share price was steady at CN¥17.53 over the past week.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.공시 • Dec 01Valiant Co.,Ltd Approves Election of Lv Shaoyang as DirectorValiant Co.,Ltd announced at the EGM held on November 29, 2022 that the company approved Election of Lv Shaoyang as a director.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Price Target Changed • Nov 03Price target decreased to CN¥23.80Down from CN¥27.68, the current price target is an average from 2 analysts. New target price is 63% above last closing price of CN¥14.63. Stock is down 30% over the past year. The company is forecast to post earnings per share of CN¥0.93 for next year compared to CN¥0.69 last year.Reported Earnings • Oct 28Third quarter 2022 earnings: EPS exceeds analyst expectationsThird quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 21Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.공시 • May 31Valiant Co.,Ltd Announces Cash Dividend, Payable on 06 June 2022Valiant Co.,Ltd announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 2.55000000. Record date as 02 June 2022, ex-date as 06 June 2022 and payment date as 06 June 2022.Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 9.4%. Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Mar 29+ 1 more updateValiant Co., Ltd. Proposes Final Cash Dividend for the Year 2021Valiant Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 2.55000000 for the year 2021.Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.Buying Opportunity • Feb 11Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Buying Opportunity • Jan 25Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be CN¥26.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 171% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.00 per share.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.61 per share.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.82, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.매출 및 비용 세부 내역ValiantLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이SZSE:002643 매출, 비용 및 순이익 (CNY Millions)날짜매출순이익일반관리비연구개발비31 Mar 263,87129248145931 Dec 253,71728448643930 Sep 253,75725648442530 Jun 253,60724947041631 Mar 253,61722847741531 Dec 243,69324649442330 Sep 243,89248449141030 Jun 244,18858951541831 Mar 244,21068551239831 Dec 234,30576349436530 Sep 234,41265357235330 Jun 234,56762059732831 Mar 234,74266559433901 Jan 235,08072157835830 Sep 224,97777850435130 Jun 225,13581645937631 Mar 224,94372844833801 Jan 224,35962743729530 Sep 214,19364940231330 Jun 213,48158937225931 Mar 213,03651235124031 Dec 202,91850534125030 Sep 202,87748934722430 Jun 202,82449235021431 Mar 202,87753035823231 Dec 192,87050736221930 Sep 192,72550537221630 Jun 192,64748236921131 Mar 192,63648237918331 Dec 182,63244437319430 Sep 182,50938935816130 Jun 182,47236428922331 Mar 182,50235031118531 Dec 172,45638534713630 Sep 172,3203703639830 Jun 172,221347454031 Mar 172,037328431031 Dec 161,847319378030 Sep 161,933363339030 Jun 161,904373309031 Mar 161,788324279031 Dec 151,631258283030 Sep 151,386179256030 Jun 151,2511302350양질의 수익: 002643는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 002643의 현재 순 이익률 (7.6%)은 지난해 (6.3%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 002643의 수익은 지난 5년 동안 연평균 17.1% 감소했습니다.성장 가속화: 지난 1년간 002643 의 수익 증가율(28.4%)은 연간 평균(-17.1%)을 초과합니다.수익 대 산업: 002643의 지난 1년 수익 증가율(28.4%)은 Chemicals 업계의 3.7%를 상회했습니다.자기자본이익률높은 ROE: 002643의 자본 수익률(4.9%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 14:09종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Valiant Co.,Ltd는 11명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiongwei JiaChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Nai Di ZhaoEverbright Securities Co. Ltd.8명의 분석가 더 보기
Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026
공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025
Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026
Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.
공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025
Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.
Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.
공시 • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025
Declared Dividend • Jun 01Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 67% lower than last year. Ex-date: 6th June 2025 Payment date: 6th June 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (42% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 139% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.
Board Change • Apr 30High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman of the Supervisory Board Lei Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.
Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (down from CN¥0.11 in 1Q 2024). Revenue: CN¥861.2m (down 8.2% from 1Q 2024). Net income: CN¥79.9m (down 19% from 1Q 2024). Profit margin: 9.3% (down from 11% in 1Q 2024). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
공시 • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Buy Or Sell Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock has risen 3.7% to CN¥10.99. The fair value is estimated to be CN¥13.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
공시 • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
분석 기사 • Mar 25Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its EarningsValiant Co.,Ltd's ( SZSE:002643 ) price-to-earnings (or "P/E") ratio of 21.4x might make it look like a buy right now...
분석 기사 • Mar 07There Are Reasons To Feel Uneasy About ValiantLtd's (SZSE:002643) Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
분석 기사 • Feb 21We Think ValiantLtd (SZSE:002643) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Buy Or Sell Opportunity • Feb 13Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥10.79. The fair value is estimated to be CN¥13.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.60, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.59 per share.
Buy Or Sell Opportunity • Jan 02Now 24% undervaluedOver the last 90 days, the stock has risen 9.0% to CN¥11.30. The fair value is estimated to be CN¥14.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
공시 • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025
분석 기사 • Dec 18Calculating The Fair Value Of Valiant Co.,Ltd (SZSE:002643)Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥14.68 Current share price...
분석 기사 • Dec 04Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 31% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have continued their recent momentum with a 31% gain in the last month alone...
Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.42, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.52 per share.
분석 기사 • Nov 26ValiantLtd (SZSE:002643) Could Be Struggling To Allocate CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.
Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.
분석 기사 • Nov 05ValiantLtd's (SZSE:002643) Shareholders Have More To Worry About Than Only Soft EarningsThe market wasn't impressed with the soft earnings from Valiant Co.,Ltd ( SZSE:002643 ) recently. We did some analysis...
Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.
Buy Or Sell Opportunity • Oct 11Now 20% undervaluedOver the last 90 days, the stock has risen 2.1% to CN¥9.77. The fair value is estimated to be CN¥12.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.
분석 기사 • Oct 08Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 40% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have had a really impressive month, gaining 40% after a shaky period beforehand...
공시 • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.08 per share.
분석 기사 • Sep 05Are Investors Undervaluing Valiant Co.,Ltd (SZSE:002643) By 30%?Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥12.10 ValiantLtd's...
Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.
Price Target Changed • Aug 27Price target decreased by 9.2% to CN¥16.63Down from CN¥18.31, the current price target is an average from 4 analysts. New target price is 107% above last closing price of CN¥8.03. Stock is down 54% over the past year. The company is forecast to post earnings per share of CN¥0.90 for next year compared to CN¥0.84 last year.
Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
분석 기사 • Aug 19Lacklustre Performance Is Driving Valiant Co.,Ltd's (SZSE:002643) Low P/EWith a price-to-earnings (or "P/E") ratio of 11.7x Valiant Co.,Ltd ( SZSE:002643 ) may be sending very bullish signals...
분석 기사 • Jul 18We Think ValiantLtd (SZSE:002643) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
공시 • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024
분석 기사 • Jun 21Return Trends At ValiantLtd (SZSE:002643) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
분석 기사 • Jun 02ValiantLtd (SZSE:002643) Has Announced That It Will Be Increasing Its Dividend To CN¥0.30Valiant Co.,Ltd ( SZSE:002643 ) will increase its dividend on the 6th of June to CN¥0.30, which is 1.7% higher than...
Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.
Major Estimate Revision • May 23Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2024 has been updated. 2024 consensus EPS increased from CN¥0.831 to CN¥0.947. Revenues were reaffirmed at CN¥4.86b. Net income forecast to grow 36% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥18.25. Share price was steady at CN¥11.44 over the past week.
분석 기사 • Apr 26Solid Earnings May Not Tell The Whole Story For ValiantLtd (SZSE:002643)The stock price didn't jump after Valiant Co.,Ltd ( SZSE:002643 ) posted decent earnings last week. We did some digging...
Major Estimate Revision • Apr 26Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥5.58b to CN¥4.86b. EPS estimate fell from CN¥1.04 to CN¥0.831 per share. Net income forecast to grow 21% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥20.64 to CN¥18.31. Share price fell 8.4% to CN¥11.31 over the past week.
분석 기사 • Apr 23What Does The Future Hold For Valiant Co.,Ltd (SZSE:002643)? These Analysts Have Been Cutting Their EstimatesThe analysts covering Valiant Co.,Ltd ( SZSE:002643 ) delivered a dose of negativity to shareholders today, by making a...
Price Target Changed • Apr 22Price target decreased by 7.3% to CN¥19.14Down from CN¥20.64, the current price target is an average from 4 analysts. New target price is 72% above last closing price of CN¥11.12. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.84 last year.
공시 • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 08Price target decreased by 12% to CN¥20.64Down from CN¥23.54, the current price target is an average from 4 analysts. New target price is 58% above last closing price of CN¥13.02. Stock is down 26% over the past year. The company is forecast to post earnings per share of CN¥0.85 for next year compared to CN¥0.79 last year.
공시 • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024
분석 기사 • Mar 22ValiantLtd (SZSE:002643) Has More To Do To Multiply In Value Going ForwardDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
분석 기사 • Mar 06Valiant Co.,Ltd's (SZSE:002643) Shares Leap 27% Yet They're Still Not Telling The Full StoryThose holding Valiant Co.,Ltd ( SZSE:002643 ) shares would be relieved that the share price has rebounded 27% in the...
분석 기사 • Feb 28Is Valiant Co.,Ltd (SZSE:002643) Potentially Undervalued?While Valiant Co.,Ltd ( SZSE:002643 ) might not have the largest market cap around , it received a lot of attention...
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
공시 • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings: EPS exceeds analyst expectationsThird quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Oct 30Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.91b to CN¥4.37b. EPS estimate unchanged at CN¥0.881 per share. Net income forecast to grow 47% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 8.8% to CN¥16.97 over the past week.
공시 • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.
Reported Earnings • Aug 19Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 6.7%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.
Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
공시 • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023
Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
공시 • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.
Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.
Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Apr 21Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.80b to CN¥5.14b. EPS estimate fell from CN¥1.10 to CN¥0.923 per share. Net income forecast to grow 9.3% next year vs 38% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥22.59. Share price was steady at CN¥17.53 over the past week.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
공시 • Dec 01Valiant Co.,Ltd Approves Election of Lv Shaoyang as DirectorValiant Co.,Ltd announced at the EGM held on November 29, 2022 that the company approved Election of Lv Shaoyang as a director.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Price Target Changed • Nov 03Price target decreased to CN¥23.80Down from CN¥27.68, the current price target is an average from 2 analysts. New target price is 63% above last closing price of CN¥14.63. Stock is down 30% over the past year. The company is forecast to post earnings per share of CN¥0.93 for next year compared to CN¥0.69 last year.
Reported Earnings • Oct 28Third quarter 2022 earnings: EPS exceeds analyst expectationsThird quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 21Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
공시 • May 31Valiant Co.,Ltd Announces Cash Dividend, Payable on 06 June 2022Valiant Co.,Ltd announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 2.55000000. Record date as 02 June 2022, ex-date as 06 June 2022 and payment date as 06 June 2022.
Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 9.4%. Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.
Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Mar 29+ 1 more updateValiant Co., Ltd. Proposes Final Cash Dividend for the Year 2021Valiant Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 2.55000000 for the year 2021.
Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.
Buying Opportunity • Feb 11Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Buying Opportunity • Jan 25Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be CN¥26.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 171% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.00 per share.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.61 per share.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.82, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.